Trust Co. of Vermont Grows Position in Align Technology, Inc. (NASDAQ:ALGN)

Trust Co. of Vermont lifted its stake in Align Technology, Inc. (NASDAQ:ALGN) by 332.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 692 shares of the medical equipment provider’s stock after acquiring an additional 532 shares during the period. Trust Co. of Vermont’s holdings in Align Technology were worth $144,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in ALGN. True Wealth Design LLC lifted its holdings in shares of Align Technology by 10,700.0% in the third quarter. True Wealth Design LLC now owns 108 shares of the medical equipment provider’s stock worth $27,000 after buying an additional 107 shares in the last quarter. University of Texas Texas AM Investment Management Co. bought a new stake in Align Technology during the 2nd quarter worth approximately $31,000. Quarry LP lifted its stake in Align Technology by 53.0% in the 2nd quarter. Quarry LP now owns 127 shares of the medical equipment provider’s stock worth $31,000 after purchasing an additional 44 shares in the last quarter. Neo Ivy Capital Management bought a new position in Align Technology in the 3rd quarter valued at $32,000. Finally, CVA Family Office LLC grew its position in shares of Align Technology by 85.2% during the 3rd quarter. CVA Family Office LLC now owns 150 shares of the medical equipment provider’s stock valued at $38,000 after purchasing an additional 69 shares in the last quarter. Institutional investors own 88.43% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on ALGN shares. Stifel Nicolaus dropped their price objective on Align Technology from $285.00 to $275.00 and set a “buy” rating for the company in a research note on Thursday, October 24th. Needham & Company LLC reissued a “hold” rating on shares of Align Technology in a report on Monday, November 4th. Robert W. Baird lowered their target price on shares of Align Technology from $325.00 to $276.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. Morgan Stanley cut their price target on shares of Align Technology from $310.00 to $280.00 and set an “overweight” rating for the company in a research note on Thursday, October 24th. Finally, Bank of America raised their price objective on shares of Align Technology from $200.00 to $206.00 and gave the company an “underperform” rating in a research report on Friday, December 13th. Two research analysts have rated the stock with a sell rating, two have given a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $268.20.

Align Technology Price Performance

Shares of Align Technology stock opened at $224.23 on Monday. The stock has a market capitalization of $16.74 billion, a P/E ratio of 38.26, a price-to-earnings-growth ratio of 4.64 and a beta of 1.67. Align Technology, Inc. has a one year low of $196.09 and a one year high of $335.40. The business’s 50 day simple moving average is $222.11 and its two-hundred day simple moving average is $228.19.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings results on Wednesday, October 23rd. The medical equipment provider reported $2.35 EPS for the quarter, beating analysts’ consensus estimates of $2.31 by $0.04. The company had revenue of $977.87 million during the quarter, compared to analyst estimates of $990.05 million. Align Technology had a net margin of 11.15% and a return on equity of 13.99%. The firm’s revenue was up 1.8% compared to the same quarter last year. During the same period in the prior year, the business posted $1.62 EPS. Sell-side analysts expect that Align Technology, Inc. will post 7.44 earnings per share for the current fiscal year.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.